The North America Radiotherapy Market would witness market growth of 5.6% CAGR during the forecast period (2022-2028).
Radiation therapy could be the only option for some patients. However, radiation therapy is typically combined with other cancer treatments such as chemotherapy, surgery, and immunotherapy. To increase the likelihood that the treatment will be effective, radiation therapy may be administered before, during, or after these supplement therapies. The type of cancer being addressed and whether the purpose of radiation therapy is to cure the disease or ease symptoms would determine when radiation therapy is administered.
Radiotherapy is the practice of treating cancer with radiation, most frequently x-rays. Internal radiotherapy refers to radiotherapy that is administered within the body, alternatively, external radiation comes from outside the body. In an effort to treat cancer, lessen the likelihood that it will return, or simply help with symptom relief, radiotherapy may be employed. It may be used alone or in conjunction with other therapies like chemotherapy or surgery. A significant number of cancer patients need radiotherapy at some time during their course of treatment. Radiotherapy typically uses photons.
There is a significant prevalence of several types of cancers in the region. According to the National Cancer Institution, in the United States, there were approximately 1,806,590 new instances of cancer diagnosed in 2020, and there were also likely be 606,520 cancer-related deaths. The most prevalent cancers across this region are lung and bronchus cancer, breast cancer, colon and rectum cancer, prostate cancer, melanoma of the skin, non-Hodgkin lymphoma, bladder cancer, kidney as well as renal pelvis cancer, leukemia, pancreatic cancer, endometrial cancer, thyroid cancer, and liver cancer. An estimated 43% of all malignancies diagnosed in males in 2020 are colorectal, lung, and prostate cancers.
The US market dominated the North America Radiotherapy Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2,566.2 million by 2028. The Canada market is poised to grow at a CAGR of 8% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 7.1% during (2022 - 2028).
Based on End User, the market is segmented into Hospitals & Clinics and Others. Based on Type, the market is segmented into External Beam Radiation Therapy, Internal Radiation Therapy and Systemic Radiation Therapy. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Radiotherapy Market is Estimated to reach $9.3 Billion by 2028, at a CAGR of 41.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Siemens Healthineers AG, Accuray, Incorporated, Elekta AB, Eckert & Ziegler AG, Ion Beam Applications SA, iCAD Inc., Isoray Inc., Mevion Medical Systems, Inc., and Nordion Inc. (Sotera Health LLC).
By End User
By Type
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
